Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News DocuSign Inc DOCU

DocuSign, Inc. provides electronic signature solution in the United States and internationally. The company offers AI-powered intelligent agreement management (IAM) platform to optimize the agreement management process and provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the... see more

Bullboard Posts (NDAQ:DOCU)

#docusign $docu ... no buyer ... back to recent sub $40 inco

#docusign $docu ... no buyer ... back to recent sub $40 incoming re due diligence.  DOCU Stock Price | DocuSign Inc. Stock Quote...
Active_Trader - February 6, 2024

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
Melany4 - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   
Melany4 - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
Melany4 - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
Melany4 - June 2, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
Melany4 - May 11, 2022